Tumor-specific mutations have not been reported in EpCAM so far, while hyperglycosylation of EpCAM at N74, N111, and N198 in carcinoma was commonly seen compared to normal epithelia [8,9,10]. This evidence concerns the gene EPCAM and neoplasm.